Pealkiri: 

The state of the drugs problem in the acceding and candidate countries to the European Union 2003

Väljaandja/tellija: EMCDDA
Märksõnad: narkomaania, narkootikumid, sõltuvushäired, Euroopa, alkohol, noored, ravi, kahjude vähendamine, tervisepoliitika, seadused, nakkushaigused, HIV, C-hepatiit, B-hepatiit, AIDS, tuberkuloos, riskikäitumine, asendusravi, vaktsineerimine, nõustamine, terviseteenused
Välja antud: 2003
Tüüp: Raport
Failid:
Nimi SuurusFormaat
EMCDDA2003.pdf906.3 kBAdobe PDF
Alamvaldkonnad:Sõltuvusainete tarvitamine
Tervisenäitajate siseriiklik ja rahvusvaheline võrdlus
Nakkushaigused
Riskikäitumine
Tervisepoliitika planeerimine ja juhtimine
Terviseteenuste korraldus, kättesaadavus ja kvaliteet
Tervisepoliitika rakendamine ja hindamine
Kirjeldus: Contents

Foreword ..................................................................................7
Acknowledgements ...................................................................9
Note ........................................................................................9
Introduction .............................................................................11
Chapter 1: Overview of the drugs situation
in the CEECs - situation and responses
Historical overview ....................................................................13
Thematic analysis of situation and responses............................. 17
Public health and social policy: key challenges for the future........ 31
Chapter 2: Drug and alcohol use among young people
Main findings ............................................................................35
Comparative analysis of available data ........................................37
Health and social consequences ................................................40
Demand and harm reduction responses ......................................41
Conclusions .............................................................................44
Chapter 3: Drug-related infectious diseases
Introduction ..............................................................................47
Prevalence of and trends in HIV infection .....................................48
Prevalence of and trends in hepatitis C infection ...........................49
Hepatitis B infection ..................................................................50
Tuberculosis and other diseases ................................................51
Drug-related infectious diseases¿ risk behaviour ...........................51
Substitution treatment ...............................................................54
Vaccination against hepatitis B ..................................................54
Access to counselling and testing ..............................................55
Access to treatment .................................................................55
Summary and conclusions ........................................................55
Chapter 4: Characteristics of drug strategies
in the acceding and candidate countries
Introduction ..............................................................................59
Legislation ...............................................................................59
National drug strategies .............................................................60
Conclusions ..............................................................................68
Bibliography ..............................................................................73
National focal points in the acceding and candidate countries ........77